Borrelli · Journal of pain & palliative care pharmacotherapy 2026 · narrative review · n=16 studies

The Risk of Chronic Opioid Utilization with Tramadol: A Narrative Review of the Literature.

Cited 0 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review without systematic search or meta-analysis methodology

PubMed 41031407 · doi:10.1080/15360288.2025.2562033 · record verified 2026-08-26

What was done

A narrative review evaluating published literature on the impact of tramadol on chronic opioid utilization and/or opioid misuse compared to other opioid therapies.

What was found

Ten published studies reported that tramadol had a comparable or higher risk of chronic opioid utilization and/or opioid misuse compared to other opioids, while six studies reported a significantly lower risk. The abstract reports no pooled numerical effect sizes or participant counts.

Why it matters

Despite its lower federal scheduling compared to other prescription opioids, multiple studies suggest tramadol may carry a comparable or greater risk of long-term use and misuse.

Limits

The paper is a narrative review without formal meta-analysis. The included observational studies are prone to confounding by indication, residual confounding, and unmeasured biases.

Cited by